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Expression of endothelln-3 mRNA along rat nephron segments using
polymerase chain reaction. Endothelin (ET) is now known to be a family
of three distinct peptides. Although many reports have studied the renal
action of ET-1, comparatively little is known concerning ET-3. We
previously reported that ET-1 mRNA is expressed in glomerulus (GIm)
and inner medullary collecting duct (IMCD). In this study, microlocal-
ization of mRNA coding ET-3 was carried out in the rat kidney using a
reverse transcription and polymerase chain reaction (RT-PCR) assay of
individual microdissected renal tubule segments along the nephron,
Glm, vasa recta bundle, and arcuate arteries. Large signals for ET-3
PCR product were detected in proximal convoluted and straight tu-
bules, cortical collecting duct, and outer medullary collecting duct.
GIm, IMCD, and vasa recta bundle also expressed relatively large
amounts of ET-3 mRNA. Small signals were found in medullary thick
ascending limb, inner medullary thin limb, and arcuate artery. We
detected ET-3 protein in tubule suspensions from cortex, outer me-
dulla, and inner medulla of rat kidney. Furthermore, incubation with
TGF-/3 did not change ET-3 PCR signal, whereas ET-1 PCR signal was
increased significantly by exposure to TGF-/3 in Glm and IMCD. Thus,
ET-3 and El-I are distributed differently along the nephron and are
regulated in different manners. This suggests that El-3 and ET-l may
affect kidney functions in different ways.
Endothelin (ET), initially described as a 21-amino-acid vaso-
active peptide secreted by cultured vascular endothelial cells
[1], is now known to be a family of three distinct peptides [2].
ET-l differs in structure from endothelin-2 (ET-2) and endothe-
lin-3 (ET-3) by two and six amino acid residues, respectively
[2]. Recently, two distinct ET receptors were described. A-type
ET receptor binds ET-l with two- to 10-fold higher affinity than
ET-2 and with more than 100-fold higher affinity than ET-3 [3].
B-type ET receptor (ET-BR) has similar affinities for all three
peptides [4].
The kidney has been reported to be the production and action
site of ETs. We reported that ET-1 mRNA and protein are
present in glomerulus and inner medullary collecting duct
(IMCD) [5]. Although many reports have studied the renal
action of ET-1, comparatively little is known concerning ET-3.
Recently, several reports demonstrated that ET-3 plays some
role in maintaining glomerular function and renal blood flow
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(RBF) [6, 7]. We previously reported that ET-BR is widely
expressed along the nephron segments, and found especially
high levels in glomerulus and collecting ducts [8]; ET-3 could
modulate renal functions via ET-BR.
Recently, Firth and Ratcliffe reported that relatively large
amounts of ET-3 mRNA were expressed in the kidney [9]. ET-3
peptide was also detected in the kidney by Hemsen and
Lundberg using HPLC [10]. However, these studies did not
determine which nephron segments produce ET-3. The kidney
is a heterogenous organ, and thus information on the precise
localization and regulation of ET-3 mRNA expression seems
necessary to understand the renal actions of ET-3. ET-3 pro-
duction was reported in primary cultures of renal tubule cells
obtained from proximal tubule, medullary thick ascending limb,
cortical collecting duct, and IMCD [11]. It is not known
whether native renal tubules express ET-3 mRNA. It is also not
known whether ET-3 and ET- 1 are regulated by similar mech-
anisms. Therefore, we investigated the effects of transforming
growth factor (TGF)-13, which is known to induce ET-1 mRNA,
on the expression of ET-3 mRNA.
Recently, Moriyama et al [12] introduced a new method for
measuring relative levels of specific mRNA in microdissected
glomeruli or renal tubules using the polymerase chain reaction
(PCR) coupled to reverse transcription (RT-PCR). In the
present study, we employed this RT-PCR technique to investi-
gate the precise localization and regulation of ET-3 in micro-
dissected renal tubules, glomeruli, arcuate artery, and vasa
recta bundle.
Methods
Microdissection of nephron segments
Nephron segments were microdissected from male Sprague-
Dawley rats weighing 75 to 100 g as previously described [12,
13]. The kidney was perfused initially with 10 ml of ice-cold
dissection solution (solution 1), and then with 10 ml of the same
solution containing I mg/mI collagenase (collagenase solution)
(type I, 300 U/mg, Sigma Chemical Co., St. Louis, Missouri,
USA) and I mg/ml bovine serum albumin (Sigma). The dis-
section solution (solution I) contained the following (in mM):
135 NaCI, I Na2SO4, 1.2 MgSO4, 5 KC1, 2 CaCI2, 5.5 glucose,
and 5 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES), pH 7.4. The left kidney was removed and a coronal
section was made that contained the entire corticopapillary
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axis. This section was cut into four pieces: cortex, outer
medulla, outer 25% of inner medulla, and inner 75% of inner
medulla. These pieces were incubated in collagenase solution
for 30 minutes (cortex and outer medulla) or 40 minutes (inner
medulla) at 37°C in a shaking water bath. Next, tissues were
transferred to the dissection solution containing 10 mM vanadyl
ribonucleotide complex (Life Technologies, Inc., Gaithersburg,
Maryland, USA), a potent RNase inhibitor.
We microdissected the following structures: glomerulus
(Glm), proximal convoluted tubule (PCT), proximal straight
tubule (PST), inner medullary thin limb (IMTL), medullary
thick ascending limb (MTAL), cortical collecting duct (CCD),
outer medullary collecting duct (OMCD), the initial part of
inner medullary collecting duct (iIMCD), the terminal part of
inner medullary collecting duct (tIMCD), arcuate artery, and
vasa recta bundle (VR bundle) [12, 13].
Microdissected renal structures were washed free of contam-
inating debris and vanadyl ribonucleotide complex in a separate
wash dish containing 10 ml of the dissection solution. Gener-
ally, a 2 mm length of tubule or arcuate artery was transferred
into the appropriate RT-PCR reaction tube, containing 10 d of
ice-cold dissection solution containing > 1 U/pJ of human
placental RNase inhibitor (Boehringer-Mannheim, GmbH,
Mannheim, Germany) and 5 mrt dithiothreitol (DTF, Sigma).
Reverse transcription
Reverse transcription (RI) was performed using a cDNA
synthesis kit (Boehringer-Mannheim). The RNase-inhibitor so-
lution was removed, and 9 d of 2% Triton X- 100, containing >1
U/pi of RNase inhibitor and 5 m DTT, was added to perme-
abilize the cells. RT components were added to the reaction
tubes as described previously [12, 13]: 4 l of buffer I, 1 .d of
RNase inhibitor, 2 l of deoxynucleotide mixture (final concen-
tration was 20 nmol of dATP, dCTP, dGTP, and dTTP), 2 d of
random primer (0.04 A2 unit of p(dN)6 per reaction), and 2 d
of avian myeloblastoma virus reverse transcriptase. Reaction
tubes were incubated at 42°C for 60 minutes in the Programmed
Tempcontrol System (Astec, Tokyo, Japan). At the end of the
incubation period, the reaction was stopped by heating at 90°C
for five minutes.
Polymerase chain reaction
PCR was performed using the GeneAmp DNA Amplification
Reagent Kit (Perkin-Elmer Cetus, Norwalk, Connecticut,
USA), with rat ET-3-specific primers prepared on a DNA
synthesizer (Applied Biosystems, Tokyo, Japan). We designed
specific primers 20 to 25 nucleotides in length with 50 to 60%
GC composition. ET-3 primer I (antisense) was defined by
bases 479-499, and primer 2 (sense) encompassed bases 23-42
[14]. The sequence of ET-3 primer 1 was 5'-GCTGGTG-
GACTTTATCTGTCC-3'; primer 2 was 5'-TTCTCGGGCTCA-
CAGTGACC-3'. The predominant cDNA amplification product
was predicted to be 477 bp in length. A third oligonucleotide
was synthesized to serve as an amplification product-specific
probe. This oligonucleotide (sense) included bases 6 1-80 of the
cDNA, positioned between primer I and primer 2. The se-
quence of this oligonucleotide probe was 5'-CCTGCA-
CAGCCTGGAAATGC-3' [14].
The primers for ET-l were defined by the following cDNA
base sequences [15]: primer 1 (antisense), bases 675-699, se-
quence, 5'-AAGATCCCAGCCAGCATGGAGAGCG-3'; primer
2 (sense), bases 157-181, sequence, 5'-CGTTGCTCCTGC-
TCCTCCTTGATGG-3'. The cDNA amplification product was
predicted to be 543 bp in length. A third oligonucleotide was
synthesized to serve as an amplification product-specific probe.
This oligonucleotide (sense) included bases 302-321 of the
cDNA, positioned between primer 1 and primer 2. The se-
quence of this oligonucleotide probe was 5'-CAAAGACCACA-
GACCAAGGG-3'.
RI and PCR of glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH) served as a positive control. The primers were
defined by the following cDNA base sequences [16]: primer 1
(antisense), bases 794-813, sequence, 5'-AGATCCACAACG-
GATACATT-3'; primer 2 (sense), bases 506-525, sequence,
5'-TCCCTCAAGATFGTCAGCAA-3'. The cDNA amplifica-
tion product was predicted to be 309 bp in length. A third
oligonucleotide was synthesized to serve as an amplification
product-specific probe. This oligonucleotide (sense) included
bases 307-326 of the eDNA, positioned between primer 1 and
primer 2. The sequence of this oligonucleotide probe was
5'-ACCGCTTCCATGGCCCTGAT-3'. When GAPDH was
used as a positive control, reverse transcription was performed,
20 jii samples were then divided into 15 d for ET-l or ET-3 and
5 l for GAPDH. The volume was adjusted to 20 1.d with sterile
water. Next, parallel PCR reactions were run with each set of
primers.
To carry out the PCR, 80 d of a PCR master mix were added
to each tube directly. Fifty picomoles each of primers 1 and 2
were used per reaction. Deoxynucleotides were added to a final
concentration of 0.20 ifiM each. Reaction buffer (lOx) was
diluted (1/10) to have a final composition of: 10 mM Tris-HCI,
pH 8.3, 50mM KC1, 1.5 mi MgCl2 and 0.001% (wt/vol) gelatin,
and 2.5 units of Taq DNA polymerase. The tubes were placed
in the Programmed Tempcontrol System which was pro-
grammed as follows: (a) incubation at 94°C for three minutes
(initial melt); (b) 30 cycles of the following sequential steps:
94°C for one minute (melt); 60°C for one minute (anneal); 72°C
for three minutes (extend). (c) Finally, incubation was done at
72°C for seven minutes (final extension). We also tested specif-
ically for the possibility of a PCR "amplification plateau." We
examined the nature of the amplification for ET-3 and ET-l by
performing RT-PCR for 0, 10, 20, 30, 40, and 45 cycles on
samples of 2 mm lengths of OMCD, 10mm lengths of IMCD, or
10 GIm. The reaction was as described above, but the PCR
mixture was "spiked" with [32P-a]dATP and [32P-a}dCTP.
After electrophoresis, the ET-3 and ET-1 bands were excised
from each lane and 32P incorporation into the amplification
product was quantitated by scintillation counting of the agarose
gel piece. Plotting the number of cycles versus radioactive
counts confirmed that PCR amplification was log-linear until 40
cycles for 2 mm lengths of OMCD, 10mm lengths of IMCD, and
10 GIm (data not shown).
PCR product analysis
Ninety microliters of the total reaction volume was ethanol-
precipitated [17]. The PCR products were size-fractionated by
agarose gel electrophoresis. After electrophoresis and ethidium
bromide staining, DNA bands were visualized with an ultravi-
olet transilluminator (Funakoshi, Tokyo, Japan).
For Southern blot analysis, gels were denatured, neutralized,
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Fig. 1. Effect of reverse transcription (RT) on ET-3 and GAPDH mRNA ampl/ication. (A) Ethidium bromide stained agarose gel for ET-3. The
left lane is DNA size marker. (B) Autoradiogram of corresponding Southern blot. The blots were probed with a 32P-labeled oligonucleotide that
localized between ET-3 primers. (C) Ethidium bromide stained agarose gel for GAPDH. (D) Autoradiogram of corresponding Southern blot. The
blots were probed with a 32P-labeled oligonucleotide that localized between GAPDH primers. We obtained the same results from 3 experiments
from 3 rats.
and blotted onto a nitrocellulose filter (Funakoshi). The syn-
thetic oligonucleotide probes were end-labeled with 32P as
described previously [12, 13]. Prehybridizationlhybridization
washes were as previously described [12, 13].
To confirm that the PCR products were really ET- 1 and ET-3
cDNAs, the PCR products were sequenced. PCR products from
glomeruli were separated by gel electrophoresis. PCR products
were subcloned into pCRTM vector (Invitrogen, San Diego,
California, USA), then sequenced using the dideoxynucleotide
chain-termination reaction. To monitor the presence of cross-
contamination between other segments or debris, we have
previously conducted a study which used aldose reductase
mRNA from nephron segments as a marker [81. Distribution of
aldose reductase mRNA, which was reported present in GIm,
IMCD, and IMTL [12], was studied to rule out the possibility
that other segments were contaminated by IMCD or Glm. We
did not detect any aldose reductase band in other segments [81.
This suggested that there was no cross-contamination between
these segments. We also performed RT-PCR for ET-3 and ET-l
in the absence of template, to monitor the presence of contam-
ination. We did not detect any band in the absence of template
(data not shown).
ET-3 and ET-1 mRNA expressions in Gim and JMCD
incubated with TGF-/3
To investigate the effect of TGF-f3 on ET-l and ET-3 mRNA
expressions, 10 Gim or 10 mm lengths of microdissected IMCD
were incubated in dissection solution described above, with or
without TGF-p (16 nglml) (Collaborative Research, Inc., Bed-
ford, Massachusetts, USA) in the presence of 0.5% fetal calf
serum (FCS) (Life Technologies, Inc., Gaithersburg, Maryland,
USA) for six hours at 37°C with oxygen supply. In our previous
study [5], we have observed that ET-l production was in-
creased during 16 hours in this incubation condition; thus, we
felt certain that GIm and IMCD are viable for six hours in this
condition.
Relative quantitation of mRNA levels from autoradiographs
The PCR product for ET-3 was detected from several
nephron segments. The relative amount of PCR product was
determined by densitometric scanning of autoradiographs using
a laser densitometer (Hoefer Scientific Instruments, San Fran-
cisco, California, USA). Each RT-PCR experiment included
one or more OMCD samples. For relative quantitation, we used
the densitometry value from the OMCD samples as an internal
standard (100%) and calculated the percentage of the OMCD
value for each segment.
To test the relationship between the quantity of starting
material and that of amplification product of 30 cycles PCR as
reflected by densitometric analysis, we compared the densi-
tometry value obtained from the amplification product from
several lengths of OMCD (0.2 to 2.0 mm, N = 12). We also
compared the densitometry value obtained from the amplifica-
tion product of 30 cycles PCR from several lengths of IMCD
(1.0 to 20.0 mm, N = 12), and several numbers of Glm (1 to 20
GIm, N = 12) to test the relationship between the quantity of
starting material and that of amplification product.
Measurement of ET-3 production in tubule suspensions and
microdissected nephron segments
Kidneys from male Sprague-Dawley rats weighing 150 g to
250 g were used to make tubule suspensions as previously
described [5]. In brief, after perfusion with solution 1, the left
kidney was divided into three parts: cortex, outer medulla, and
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inner medulla. After mincing, each part was incubated in
solution 1 with 0.1% BSA and 0.1% collagenase (Sigma Chem-
ical) in the presence of 100% 02 for 30 minutes (for cortical
tubule suspensions) or 45 minutes (for outer and inner medul-
lary tubule suspensions). Microdissected nephron segments
were Glm, PCT, MTAL, OMCD, and IMCD. Two hundred
GIm or 100 mm lengths of tubules were used as one sample to
determine ET-3 production. The final volume of each sample
was 300 sl; the tubule suspension or nephron segments were
homogenized using an ultrasonicator (Central, Tokyo, Japan),
and centrifuged for 10 minutes at 3,000 rpm at 4°C. The
supernatant was frozen until ET-3 was assayed. ET-3 was
extracted using Sep-Pak C18 cartridges (Water Assoc., Milford,
Massachusetts, USA). The RIA of ET-3 was performed using
ET-3-specific antibody (Peninsula Laboratories, Belmont, Cal-
ifornia) after extraction of samples [18].
Statistics
The results were expressed as means SEM. The differences
were tested using analysis of variance. P < 0.05 was considered
significant.
Results
Effect of reverse transcription on ET-3 and GAPDH mRNA
ampl(fication
With reverse transcription, we detected a clear single band,
which was the predicted size of 477 bp for ET-3, from OMCD
(Fig. 1, A and B). When the PCR procedure was carried out in
the absence of reverse transcriptase, the 477 bp band was not
seen and there was no other recognizable band. With reverse
transcription, we detected a clear single band, which was the
predicted size of 309 bp for GAPDH, from OMCD (Fig. 1, C
and D). When the PCR procedure was carried out in the
absence of reverse transcriptase, the 309 bp band was not seen
and there was no other recognizable band. This indicated that
the 477 bp band and the 309 bp band originated from mRNA,
not from genomic DNA.
Relationship between the quantity of starting material and
that of amp! jfica:ion product
We compared amplification products of 30 cycles PCR from
several lengths of OMCD for ET-3, assigning the 2 mm OMCD
an arbitrary densitometric unit of 100 (Fig. 2). Linear regression
analysis showed high correlation between densitometry values
and the length of each tubule for ET-3 (r 0.94; Fig. 2A). We
also compared the densitometry value obtained from the am-
plification product of 30 cycles PCR from several lengths of
IMCD (1.0 to 20.0 mm, N = 12), and several numbers of GIm (1
to 20 Gim, N = 12) to test the relationship between the quantity
of starting material and that of amplification product, assigning
the 20 mm lengths of IMCD or 20 Glm an arbitrary densitomet-
nc unit of 100. Linear regression analysis showed high corre-
lation between densitometry values and the length of each
tubule (r = 0.93; Fig. 2B) or the number of GIm (r = 0.94; Fig.
2C),
Distribution of ET-3 mRNA in microdissected structures
Each reaction was performed using either the 2 mm of tubule
length, S Glm, a single VR bundle, or a 2 mm length of arcuate
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Fig. 2. Relationship between the quantity of starting material (tubular
length or glomerular number) and the resulting amplification product of
30 cycles PCR for ET-3 mRNA. An arbitrary value of 100 was assigned
to the sample representing 2 mm OMCD (tubule number = 12, from one
rat, r = 0.94) (A). An arbitrary value of 100 was assigned to the sample
representing 20 mm IMCD (sample number = 12, from one rat, r =
0.93). (B). An arbitrary value of 100 was assigned to the sample
representing 20 GIm (sample number = 12, from one rat, r = 0.94). (C).
artery. A single band of the predicted size (477 bp) was
consistently found from every renal structure (Fig. 3A). The
Southern blots of the gels demonstrated specific binding of the
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Fig. 4. Relative quantitation of ET-3 mRNA in renal nephron seg-
ments. The values for each segment are expressed as a percentage of
OMCD values obtained in the same amplification run. The total number
of each segment is five experiments from five rats.
Fig. 3. Detection of ET-3 mRNA in microdissected renal structures by
RT-PCR. (A) Ethidium bromide-stained agarose gel for ET-3. The
arrow indicates expected PCR product size (477 bp). (B) Autoradiogram
of corresponding Southern blot for ET-3. The blots were probed with a
32P-labeled oligonucleotide that localized between the PCR primers. (C)
Ethidium bromide stained agarose gel of GAPDH as a positive control.
The arrow indicates expected PCR products size (309 bp). We obtained
the same results from five experiments from five rats. Abbreviations
are: Gim, glomerulus; PCT, proximal convoluted tubule; PST, proximal
straight tubule; IMTL, inner medullary thin limb; MTAL, medullary
thick ascending limb; CCD, cortical collecting duct; OMCD, outer
medullary collecting duct; IMCD, initial inner medullary collecting
duct; tIMCD, terminal inner medullary collecting duct; YR bundle,
vasa recta bundle.
0.
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FIg. 5. ET-3 production in tubule suspensions from cortex, outer
medulla, and innermedulla of rats. ET-3 in the supernatants of tubule
suspensions from cortex, outer medulla, and inner medulla was mea-
sured using radioimmunoassay (N = 5, mean SEM).
collecting duct segments, the values were the following: CCD,
59. 7 11.4%; iIMCD, 32.9 7.0%; and tIMCD, 27.5 9.1%.
ET-3 production by tubule suspensions of cortex, outer
medulla, and inner medulla
ET-3 contents in tubule suspensions are shown in Figure 5.
The amounts of ET-3 in tubule suspensions from inner medulla
and outer medulla are 3.5 1.3 and 3.2 0.7 pg/mg protein (N
= 5, mean SEM), respectively. Tubule suspension from cortex
PCT PST IMTL MTAL CCD OMCD iIMCD tIMCD
5
4
3
2
1
0
Outer InnerCortex medulla medulla
oligonucleotide probe to the 477 bp product (Fig. 3B). We
confirmed that the PCR product was ET-3 cDNA by sequencing
the subcloned PCR product.
Large signals for ET-3 were detected in OMCD, CCD, PCT,
PST, GIm, and YR bundle. Small signals were found in iIMCD,
tIMCD, MTAL, IMTL, and arcuate artery. Amplification prod-
uct of GAPDH was detected from all renal structures at the
predicted size (309 bp), and served as a positive control for the
RT-PCR reaction (Fig. 3C).
Relative levels of the ET-3 amp! jfication products among the
nephron segments
The densitometry values are presented as percentages of the
2 mm OMCD values measured in the same experiment (Fig. 4).
In PCT and PST, the signals were 61.9 12.5% (vs. OMCD, N
= 5) and 56.3 6.3%, respectively. The values in IMTL and
MTAL were 5.1 2.5% and 9.6 4.4%, respectively. Among
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Fig. 6. Effect of TGF-$ on ET-3 and ET-1 mRNA expression in glomerulus and inner medullary collecting duct. A. The result from agarose gel
electrophoresjs for ET-3 in Gim and IMCD. B. The corresponding Southern blot analysis. D. The result from agarose gel electrophoresis for ET-l
in GIm and IMCD. E. The corresponding Southern blot analysis. GAPDH is shown in C and F as a positive control. We obtained similar results
from five experiments from five rats.
Rh H
TGF-3 (—) (+) (—) (+) (—) (+) (—) (+)
Gim IMCD Glm IMCD
ET-3 ET-1
Fig. 7. Densitometric analysis of the effect of TGF-/3 on ET-3 and ET-1
mRNA expression in glornerulus and inner medullaty collecting duct.
This figure shows densitometry analysis of five experiments from five
rats. Each bar represents mean SEM. We expressed the densitometric
values of ET-l or ET-3 incubated with TGF-/3 as a percentage the
values of the sample incubated without TGF-/3, and those values were
also corrected by the densitometric value of GAPDH. ET-l PCR
products from Glm and IMCD incubated with TGF-/3 increased signif-
icantly from the samples incubated without TGF-13 (* P < 0.01 vs.
Control).
contains 1.7 0.4 pg/mg protein. The levels of ET-3 from
microdissected nephron segments (200 GIm or 100 mm of PCT,
MTAL, OMCD, and IMCD) are below the detectable range.
ET-3 and ET-1 mRNA regulation by TGF-f3 in Gim and
IMCD
Figure 6 A and B show a typical agarose gel and correspond-
ing Southern blot of ET-3. Incubation with or without TGF-/3 in
the presence of 0.5% FCS caused no significant change of ET-3
PCR product, both in Glm and IMCD. On the other hand, ET-1
PCR product showed a significant increase in the presence of
TGF-p in both GIm and IMCD (Fig. 6 D and E), as we reported
previously [5]. The internal standard, GAPDH, showed almost
the same intensity with and without TGF-p (Fig. 6 C and F). We
obtained similar results from five experiments from five rats.
Figure 7 shows densitometry analysis of each experiment. We
expressed the densitometric values of ET-1 or ET-3 incubated
with TGF-/3 as a percentage of the values of the sample
incubated without TGF-/3, and these values were corrected by
the densitometric value of GAPDH. The percentages of ET-3
PCR products from Glm and IMCD incubated with TGF-f3 are
92.3 20.1% (N = 5, mean SEM), and 88.6 32.3%,
respectively (Fig. 7). The percentages of ET-1 PCR products
from Glm and IMCD incubated with TGF-13 increased signifi-
cantly, to 351.7 52.0% (N = 5, mean SEM) and 446.1
70.3%, respectively (Fig. 7). Thus TGF-13 regulated the expres-
sion of ET-1 mRNA, but not ET-3 mRNA, in our experimental
condition.
Discussion
The main result of our study is that almost every nephron
segment and the renal vascular system express ET-3 mRNA.
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Incubation with TGF-/3 did not change the ET-3 PCR signal,
whereas the ET-l PCR signal was increased significantly by
exposure to TGF-p in GIm and IMCD. We found especially
high mRNA levels in OMCD, PCT, CCD, PST, and GIm. Thus,
ET-3 and ET- 1 are distributed differently along the nephron and
are regulated in different manners. We detected ET-3 protein
from tubule suspensions from cortex, outer medulla, and inner
medulla. Our results show that ET-l and ET-3 mRNA are
regulated differently in GIm and IMCD. ET-l and ET-3 may
play different roles in modulating renal function, because their
localization and regulation are different. In the following sec-
tions, we will discuss the potential role of ET-3 in the kidney.
To our knowledge, this is the first report which clearly
demonstrates that ET-3 mRNA is expressed in intact Gim.
Although Kasinath et al, using immunocytochemistry, reported
that cultured glomerular epithelial cells synthesized ET-3 [19],
it had not been shown whether intact GIm expressed ET-3
mRNA. In isolated perfused rat kidney, ET-3 markedly in-
creased GFR, fractional excretion of water and electrolytes,
and urinary excretion of PGE2 and PGF2 [6]. Yamashita et al
also reported that continuous infusion of ET-3 increased RBF
and urine flow rate, presumably via enhanced renal production
of NO induced by ET-3 [7]. We previously reported that
ET-BR, constitutive NO synthase, and soluble guanylate cy-
clase mRNAs were expressed in GIm, arcuate artery, and YR
bundle [8, 20]. In addition, ET-3 stimulates cGMP production in
isolated rat glomerulus (21). Therefore, ET-3 that is synthesized
in Glm, arcuate artery, and VR bundle may act in an autocrine
or paracrine fashion and stimulate ET-BR, and may regulate
RBF and medullary blood flow via NO, PGs, and cGMP
synthesis.
Firth and Ratcliffe reported that ET-3 mRNA expression was
at relatively high levels in the kidney [9]. Our data demonstrate
that in collecting ducts, especially in OMCD, a relatively high
amount of ET-3 mRNA is expressed. Kohan had demonstrated
that the largest ET-3 production was found in IMCD cells, but
he did not examine OMCD cells [11]. We also detected ET-3
protein in tubule suspensions from outer medulla and inner
medulla. The reason we could not detect ET-3 protein from
microdissected OMCD or IMCD is because the lower limit of
sensitivity for ET-3 measurement is around 1 pg. To collect
several mg protein from microdissected tubule is not practical,
because it requires more than 10,000 mm lengths of tubules.
Urine flow increases approximately twofold during ET-3
infusion, and urinary osmolality decreases markedly [71. This
suggests that ET-3 modulates the function of the distal nephron.
Our previous report showed that ET-BR mRNA was expressed
in collecting ducts [8]. Thus ET-3 synthesized locally may bind
to ET-BR in the collecting ducts in an autocnne or paracrine
fashion and influence water and electrolyte transport. In these
segments, ET-l is already known to influence vasopressin-
induced cAMP levels and suppress water permeability [22].
ET-3, like ET-1, could influence the function of collecting ducts
via ET-BR.
Our data show that PCT and PST express large amounts of
ET-3 mRNA. Kohan showed that the ratio of ET-3 to ET-l
accumulation was greatest in proximal tubule cells [111. Our
previous report demonstrated that ET-l mRNA could not be
detected in PCT [5]. These results suggested that proximal
tubules synthesize mainly ET-3 rather than ET-1.
Our results demonstrated that ET-1 mRNA increased in the
presence of TGF-/3 in GIm and IMCD, whereas we could not
detect an ET-3 mRNA change by incubation with TGF-/3. Our
experimental condition is relatively specific for seeing the gene
regulation, because we used intact Glm or IMCD in a six hour
incubation. We have not done other experiments using a
cultured cell system or different incubation conditions. Thus, it
seems difficult to conclude whether or not ET-3 gene transcrip-
tion is regulated by TGF-f3 only from our observations. The 5'
flanking region of the ET-l gene contains the consensus se-
quence of the binding site of nuclear factor-l, which may
mediate induction by TGF-13 [23]. On the other hand, informa-
tion on the 5' flanking region of ET-3 gene is not yet available.
Our approach to the relative quantitation of the ET-3 PCR
amplification product was to run Southern blots of the amplified
cDNA using a 32P-labeled hybridization probe, and then to
assess the amount of bound radioactivity by densitometry of the
resulting autoradiograms. OMCD consistently gave a large
signal that was relatively invariant between replicates from
experiment to experiment. Therefore we used the signal of
OMCD as a control and expressed the densitometry values of
other segments as percentages of OMCD. In preliminary exper-
iments, we compared the methods of mRNA extraction. In our
case, when we extracted RNA using the acid guanidinium
thiocyanate-PhOH-chloroform method [24] or mRNA purifica-
tion kits (Pharmacia Fine Chemicals, Piscataway, New Jersey,
USA), the efficiency of RNA extraction was not stable between
samples, thus the amount of PCR product was not consistent.
We believe that our method using Triton X-lOO is the best way
to avoid instability of this step. We also compared the quanti-
tative quality of the PCR method in several PCR cycles in a
preliminary experiment. Although we observed log-linear phase
till 40 cycles, we selected only 30 cycles for ET-3 amplification.
If we amplified 35 cycles, the amount of PCR products became
large, but the accuracy of quantitative analysis became lower,
even though the PCR is log-linear phase.
We chose a simple approach to relative quantitation rather
than any of the complicated alternatives, such as competitive
PCR [25] and PATTY (PCR aided transcript titration assay)
[26], for several reasons. The ability of any method to yield
absolute quantitation remains in question and would have to be
carefully documented. The value of knowing the absolute
number of mRNA molecules present in a given cell may be
extremely limited for most physiological questions, because
there is presently no way to relate this number to the ultimate
functional expression of the gene product.
We believe that our method gives a relative measure of the
amount of ET-3 mRNA initially present in the cells. This
conclusion is based on the observation that there is an approx-
imately linear relationship between the lengths of tubules used
for the assay (that is, the amount of starting material) and the
value obtained from densitometry of the amplification product
band.
In summary, our data show that ET-3 mRNA distributes
widely along the nephron and vascular system, and large signals
were detected in PCT, PST, CCD, OMCD, and GIm. ET-3
mRNA does not change significantly in the presence or absence
of TGF-/3. ET-3 mRNA distributes and may be regulated
differently from ET-l in the rat kidney. ET-l and ET-3 may play
different roles in modulating renal functions.
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